Early research suggests a new nasal spray vaccine could protect against multiple respiratory threats.

Flu has overtaken covid in infections and hospitalizations during the winter respiratory virus season, and their virulence is ...

(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) Feb 18 (Reuters) - A two-in-one mRNA vaccine developed by Moderna that targets ...

European regulators cleared Moderna’s first-of-its-kind vaccine as US approval remains uncertain. On Friday, Moderna’s ...

The vaccine could replace the need for separate annual jabs for flu, Covid and cold viruses as well as providing defence ...

In issuing a positive recommendation, the EMA has diverged from the FDA, which has set higher approval standards for ...

If approved, mCOMBRIAX would become the first combination Covid-flu jab to gain regulatory approval anywhere across the globe.

Stanford researchers develop breakthrough nasal spray vaccine that could potentially protect against a variety of infections, ...

Scientists at Stanford Medicine have unveiled a bold new kind of “universal” vaccine that could one day protect against everything from COVID-19 and the flu to bacterial pneumonia and even common ...

Europe's medicines regulator recommended approval for Moderna's COVID and flu combination vaccine on Friday, putting it on track to become the first single shot to ...

The European Medicines Agency (EMA) announced Friday it has recommended Moderna’s combined mRNA COVID-19 and flu vaccine be ...

European regulators advanced several new medicines, including a combined flu and COVID vaccine and new treatments for rare diseases.